Treating untreated or treatment-resistant diabetes with glucokinase activator
US11872221B2 · kind B2 · utility
0Cited by
2References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 29, 2021 |
| Grant date | Jan 16, 2024 |
| Priority date | — |
| Expiry date | May 11, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein is a method of treating, preventing, or ameliorating one or more symptoms of an untreated or treatment-resistant diabetes with a glucokinase activator, optionally in combination with a dipeptidyl peptidase-4 inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.